An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Status:
RECRUITING
Trial end date:
2027-10-30
Target enrollment:
Participant gender:
Summary
This open label, dose escalation module will evaluate the safety, tolerability, PK, PD, and preliminary efficacy of PTT-4256 in participants with solid tumours using a combination of accelerated dose titration (ADT) and Bayesian Optimal Interval (BOIN) design.